ID: ALA1762075
Chembl Id: CHEMBL1762075
PubChem CID: 52915628
Max Phase: Preclinical
Molecular Formula: C13H13N3O4
Molecular Weight: 275.26
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: NC(=O)CCN1C(=O)C(=O)N(Cc2ccccc2)C1=O
Standard InChI: InChI=1S/C13H13N3O4/c14-10(17)6-7-15-11(18)12(19)16(13(15)20)8-9-4-2-1-3-5-9/h1-5H,6-8H2,(H2,14,17)
Standard InChI Key: PHQKFFKSQNNNEL-UHFFFAOYSA-N
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
| Molecular Weight: 275.26 | Molecular Weight (Monoisotopic): 275.0906 | AlogP: -0.15 | #Rotatable Bonds: 5 |
| Polar Surface Area: 100.78 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 1 |
| #RO5 Violations: ┄ | HBA (Lipinski): 7 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
| CX Acidic pKa: ┄ | CX Basic pKa: ┄ | CX LogP: -0.12 | CX LogD: -0.12 |
| Aromatic Rings: 1 | Heavy Atoms: 20 | QED Weighted: 0.60 | Np Likeness Score: -1.34 |
| 1. Rajabi M, Mansell D, Freeman S, Bryce RA.. (2011) Structure-activity relationship of 2,4,5-trioxoimidazolidines as inhibitors of thymidine phosphorylase., 46 (4): [PMID:21324566] [10.1016/j.ejmech.2011.01.035] |
Source(1):
